Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002

<p>Abstract</p> <p>Background</p> <p>The prices of reverse transcriptase (RT) inhibitors in Thailand have been reduced since December 1, 2001. It is expected that reduction in the price of these inhibitors may influence the drug resistance mutation pattern of HIV-1 amon...

Full description

Bibliographic Details
Main Authors: Watitpun Chotip, Jenwitheesuk Ekachai, Vibhagool Asda, Chantratita Wasun
Format: Article
Language:English
Published: BMC 2003-03-01
Series:Annals of Clinical Microbiology and Antimicrobials
Online Access:http://www.ann-clinmicrob.com/content/2/1/4
id doaj-88269d5c5d244011b2586b06b94a4734
record_format Article
spelling doaj-88269d5c5d244011b2586b06b94a47342020-11-25T00:24:55ZengBMCAnnals of Clinical Microbiology and Antimicrobials1476-07112003-03-0121410.1186/1476-0711-2-4Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002Watitpun ChotipJenwitheesuk EkachaiVibhagool AsdaChantratita Wasun<p>Abstract</p> <p>Background</p> <p>The prices of reverse transcriptase (RT) inhibitors in Thailand have been reduced since December 1, 2001. It is expected that reduction in the price of these inhibitors may influence the drug resistance mutation pattern of HIV-1 among infected people. This study reports the frequency of HIV-1 genetic mutation associated with drug resistance in antiretroviral-treated patients from Thailand.</p> <p>Methods</p> <p>Genotypic resistance testing was performed on samples collected in 2002 from 88 HIV-1 infected individuals. Automated DNA sequencing was used to genotype the HIV-1 polymerase gene isolated from patients' plasma.</p> <p>Results</p> <p>Resistance to protease inhibitors, nucleoside and non-nucleoside reverse transcriptase inhibitors were found in 10 (12%), 42 (48%) and 19 (21%) patients, respectively. The most common drug resistance mutations in the protease gene were at codon 82 (8%), 90 (7%) and 54 (6%), whereas resistant mutations at codon 215 (45%), 67 (40%), 41 (38%) and 184 (27%) were commonly found in the RT gene. This finding indicates that genotypic resistance to nucleoside reverse transcriptase inhibitors was prevalent in 2002. The frequency of resistant mutations corresponding to non-nucleoside reverse transcriptase inhibitors was three times higher-, while resistant mutation corresponding to protease inhibitors was two times lower than those frequencies determined in 2001.</p> <p>Conclusion</p> <p>This study shows that the frequencies of RT inhibitor resistance mutations have been increased after the reduction in the price of RT inhibitors since December 2001. We believe that this was an important factor that influenced the mutation patterns of HIV-1 protease and RT genes in Thailand.</p> http://www.ann-clinmicrob.com/content/2/1/4
collection DOAJ
language English
format Article
sources DOAJ
author Watitpun Chotip
Jenwitheesuk Ekachai
Vibhagool Asda
Chantratita Wasun
spellingShingle Watitpun Chotip
Jenwitheesuk Ekachai
Vibhagool Asda
Chantratita Wasun
Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002
Annals of Clinical Microbiology and Antimicrobials
author_facet Watitpun Chotip
Jenwitheesuk Ekachai
Vibhagool Asda
Chantratita Wasun
author_sort Watitpun Chotip
title Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002
title_short Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002
title_full Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002
title_fullStr Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002
title_full_unstemmed Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002
title_sort prevalence of genotypic hiv-1 drug resistance in thailand, 2002
publisher BMC
series Annals of Clinical Microbiology and Antimicrobials
issn 1476-0711
publishDate 2003-03-01
description <p>Abstract</p> <p>Background</p> <p>The prices of reverse transcriptase (RT) inhibitors in Thailand have been reduced since December 1, 2001. It is expected that reduction in the price of these inhibitors may influence the drug resistance mutation pattern of HIV-1 among infected people. This study reports the frequency of HIV-1 genetic mutation associated with drug resistance in antiretroviral-treated patients from Thailand.</p> <p>Methods</p> <p>Genotypic resistance testing was performed on samples collected in 2002 from 88 HIV-1 infected individuals. Automated DNA sequencing was used to genotype the HIV-1 polymerase gene isolated from patients' plasma.</p> <p>Results</p> <p>Resistance to protease inhibitors, nucleoside and non-nucleoside reverse transcriptase inhibitors were found in 10 (12%), 42 (48%) and 19 (21%) patients, respectively. The most common drug resistance mutations in the protease gene were at codon 82 (8%), 90 (7%) and 54 (6%), whereas resistant mutations at codon 215 (45%), 67 (40%), 41 (38%) and 184 (27%) were commonly found in the RT gene. This finding indicates that genotypic resistance to nucleoside reverse transcriptase inhibitors was prevalent in 2002. The frequency of resistant mutations corresponding to non-nucleoside reverse transcriptase inhibitors was three times higher-, while resistant mutation corresponding to protease inhibitors was two times lower than those frequencies determined in 2001.</p> <p>Conclusion</p> <p>This study shows that the frequencies of RT inhibitor resistance mutations have been increased after the reduction in the price of RT inhibitors since December 2001. We believe that this was an important factor that influenced the mutation patterns of HIV-1 protease and RT genes in Thailand.</p>
url http://www.ann-clinmicrob.com/content/2/1/4
work_keys_str_mv AT watitpunchotip prevalenceofgenotypichiv1drugresistanceinthailand2002
AT jenwitheesukekachai prevalenceofgenotypichiv1drugresistanceinthailand2002
AT vibhagoolasda prevalenceofgenotypichiv1drugresistanceinthailand2002
AT chantratitawasun prevalenceofgenotypichiv1drugresistanceinthailand2002
_version_ 1725350881213284352